Sortilin levels are associated with peripheral arterial disease in type 2 diabetic subjects

[1]  C McRae,et al.  Myocardial infarction. , 2019, Australian family physician.

[2]  V. Rigalleau,et al.  Lower extremity arterial disease in patients with diabetes: a contemporary narrative review , 2018, Cardiovascular Diabetology.

[3]  S. Hadjadj,et al.  Influence of micro- and macro-vascular disease and Tumor Necrosis Factor Receptor 1 on the level of lower-extremity amputation in patients with type 2 diabetes , 2018, Cardiovascular Diabetology.

[4]  E. Aikawa,et al.  Transcriptional control of intestinal cholesterol absorption, adipose energy expenditure and lipid handling by Sortilin , 2018, Scientific Reports.

[5]  D. Rader,et al.  Autophagy Is Required for Sortilin-Mediated Degradation of Apolipoprotein B100 , 2018, Circulation research.

[6]  G. King,et al.  High density lipoprotein modulates osteocalcin expression in circulating monocytes: a potential protective mechanism for cardiovascular disease in type 1 diabetes , 2017, Cardiovascular Diabetology.

[7]  Deepak L. Bhatt,et al.  Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease , 2017, The New England journal of medicine.

[8]  S. Giovannini,et al.  Serum high mobility group box-1 and osteoprotegerin levels are associated with peripheral arterial disease and critical limb ischemia in type 2 diabetic subjects , 2017, Cardiovascular Diabetology.

[9]  Deepak L. Bhatt,et al.  Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial. , 2017, The Canadian journal of cardiology.

[10]  K. Park,et al.  Circulating sortilin level as a potential biomarker for coronary atherosclerosis and diabetes mellitus , 2017, Cardiovascular Diabetology.

[11]  Y. Bao,et al.  Elevated serum fibroblast growth factor 23 levels as an indicator of lower extremity atherosclerotic disease in Chinese patients with type 2 diabetes mellitus , 2017, Cardiovascular Diabetology.

[12]  L. Fleisher,et al.  2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2017, Journal of the American College of Cardiology.

[13]  Yang Yang,et al.  Increased sortilin and its independent effect on circulating proprotein convertase subtilisin/kexin type 9 (PCSK9) in statin-naive patients with coronary artery disease. , 2017, International journal of cardiology.

[14]  H. Hattori,et al.  Effects of Statin Therapy on Plasma Proprotein Convertase Subtilisin/kexin Type 9 and Sortilin Levels in Statin-Naive Patients with Coronary Artery Disease. , 2016, Journal of atherosclerosis and thrombosis.

[15]  A. Hirayama,et al.  Soluble sortilin is released by activated platelets and its circulating levels are associated with cardiovascular risk factors. , 2016, Atherosclerosis.

[16]  M. Suyama,et al.  TLR signals posttranscriptionally regulate the cytokine trafficking mediator sortilin , 2016, Scientific Reports.

[17]  Woocheol Lee,et al.  Introduction , 2015, Diabetes Care.

[18]  Tiangang Li,et al.  Insulin Resistance Induces Posttranslational Hepatic Sortilin 1 Degradation in Mice* , 2015, The Journal of Biological Chemistry.

[19]  D. Rader,et al.  Macrophage sortilin promotes LDL uptake, foam cell formation, and atherosclerosis. , 2015, Circulation research.

[20]  O. Jazaeri,et al.  Overview of Classification Systems in Peripheral Artery Disease , 2014, Seminars in Interventional Radiology.

[21]  E. Falk,et al.  Targeting sortilin in immune cells reduces proinflammatory cytokines and atherosclerosis. , 2014, The Journal of clinical investigation.

[22]  D. Rader,et al.  Sortilin and lipoprotein metabolism: making sense out of complexity , 2014, Current opinion in lipidology.

[23]  T. Murohara,et al.  Role of anti-inflammatory adipokines in obesity-related diseases , 2014, Trends in Endocrinology & Metabolism.

[24]  B. Roberts,et al.  Saturated fatty acids activate ERK signaling to downregulate hepatic sortilin 1 in obese and diabetic mice[S] , 2013, Journal of Lipid Research.

[25]  J. Sparks,et al.  Insulin suppression of apolipoprotein B in McArdle RH7777 cells involves increased sortilin 1 interaction and lysosomal targeting. , 2013, Biochemical and biophysical research communications.

[26]  B. Dörken,et al.  The sorting receptor Sortilin exhibits a dual function in exocytic trafficking of interferon-γ and granzyme A in T cells. , 2012, Immunity.

[27]  D. Rader,et al.  Hepatic sortilin regulates both apolipoprotein B secretion and LDL catabolism. , 2012, The Journal of clinical investigation.

[28]  D. Rader,et al.  Sortilin as a Regulator of Lipoprotein Metabolism , 2012, Current Atherosclerosis Reports.

[29]  Thomas W. Mühleisen,et al.  Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease , 2011, Nature Genetics.

[30]  M. Shin,et al.  eGFR is associated with subclinical atherosclerosis independent of albuminuria: the Dong-gu Study. , 2010, Atherosclerosis.

[31]  P. Madsen,et al.  Sort1, encoded by the cardiovascular risk locus 1p13.3, is a regulator of hepatic lipoprotein export. , 2010, Cell metabolism.

[32]  Olle Melander,et al.  From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus , 2010, Nature.

[33]  Tanya M. Teslovich,et al.  Biological, Clinical, and Population Relevance of 95 Loci for Blood Lipids , 2010, Nature.

[34]  P. Ridker,et al.  Forty-Three Loci Associated with Plasma Lipoprotein Size, Concentration, and Cholesterol Content in Genome-Wide Analysis , 2009, PLoS genetics.

[35]  Alberto Piazza,et al.  Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants , 2009, Nature Genetics.

[36]  R. Collins,et al.  Newly identified loci that influence lipid concentrations and risk of coronary artery disease , 2008, Nature Genetics.

[37]  Dolores Corella,et al.  Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans , 2008, Nature Genetics.

[38]  Mario Falchi,et al.  Genome-wide Association Study Identifies Genes for Biomarkers of Cardiovascular Disease: Serum Urate and Dyslipidemia , 2022 .

[39]  R. D'Agostino,et al.  A genome-wide association study for blood lipid phenotypes in the Framingham Heart Study , 2007, BMC Medical Genetics.

[40]  C. Gieger,et al.  Genomewide association analysis of coronary artery disease. , 2007, The New England journal of medicine.

[41]  N. Clark,et al.  Standards of Medical Care in Diabetes: Response to Power , 2006 .

[42]  R. Hoyt,et al.  Peripheral arterial disease in people with diabetes: response to consensus statement. , 2004, Diabetes care.

[43]  N. Tommerup,et al.  Molecular Identification of a Novel Candidate Sorting Receptor Purified from Human Brain by Receptor-associated Protein Affinity Chromatography* , 1997, The Journal of Biological Chemistry.

[44]  F. Becker.  Exploration of arterial function with noninvasive technics. Results in chronic arterial occlusive disease of the lower limbs according to Leriche and Fontaine classification. , 1985, International angiology : a journal of the International Union of Angiology.

[45]  E. Aikawa,et al.  Sortilin and Its Multiple Roles in Cardiovascular and Metabolic Diseases. , 2018, Arteriosclerosis, thrombosis, and vascular biology.

[46]  C. Gieger,et al.  Genetic variation at chromosome 1p13.3 affects sortilin mRNA expression, cellular LDL-uptake and serum LDL levels which translates to the risk of coronary artery disease. , 2010, Atherosclerosis.

[47]  R. Collins,et al.  Common variants at 30 loci contribute to polygenic dyslipidemia , 2009, Nature Genetics.

[48]  Christian Gieger,et al.  Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts , 2009, Nature Genetics.

[49]  Judy H. Cho,et al.  Corrigendum: Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants , 2009, Nature Genetics.

[50]  Y. Jang,et al.  Standards of Medical Care in Diabetes-2010 by the American Diabetes Association: Prevention and Management of Cardiovascular Disease , 2010 .

[51]  Peripheral Arterial Disease in People With Diabetes , 2003 .

[52]  Management of dyslipidemia in children and adolescents with diabetes. , 2003, Diabetes care.